AstraZeneca Vaccine Is Effective Against COVID-19, Phase III Study Says
Results of the trial, which involved more than 32,000 volunteers, showed two doses of the vaccine administered four weeks apart had an efficacy of 79% at preventing symptoms of COVID-19.
Read more on NPR
Results of the trial, which involved more than 32,000 volunteers, showed two doses of the vaccine administered four weeks apart had an efficacy of 79% at preventing symptoms of COVID-19.
Read more on NPR
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
Related Post
NPR News: Mushroom foragers find $4,000 worth of the fun guys known as chanterellesMushroom foragers find $4,000 worth of the fun guys known as chanterelles
Dan Gebhart and Jordan An- NPR News: For kids who survived tornadoes, Santa comes 'a little bit differently' this yearFor kids who survived tornadoes, Santa comes 'a little bit differently' this year
Holiday gift dona
- NPR News: The clear and present danger of Trump's enduring 'Big Lie'The clear and present danger of Trump's enduring 'Big Lie'
Fueling the Jan. 6 insurrection was the
- NPR News: Fauci says New York was right to ease quarantine rules for health care workersFauci says New York was right to ease quarantine rules for health care workers
Vaccinated health ca
ConversionConversion EmoticonEmoticon